Bringing Male Contraceptives To Market Could ‘Revolutionize Global Contraception Paradigm’

STAT: Getting contraceptives for men to the market will take pharma’s help
Régine Sitruk-Ware, distinguished scientist at the Population Council’s Center for Biomedical Research and co-founder of the International Consortium of Male Contraception

“…At a time when more governments are restricting access to female contraception, expanding male contraceptive options could help to make family planning more of a shared responsibility between women and men. … Bringing safe and effective male contraception options to market could revolutionize the global contraception paradigm, attract millions more customers, and prevent untold numbers of unintended pregnancies, helping couples decide whether and when to have children, and how many. … Having clear guidance and policies from the FDA and the European Medicines Agency around the regulatory process for male contraception, which exists for female contraception, will be transformational. It’s past time for industry and regulators to catch up to the science. The potential for male contraception is huge. But as researchers gathered this week [at the Second International Congress on Male Contraception in Paris], the question on everyone’s lips was, ‘When will these products ever come to market?'” (5/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.